We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Regeneron Pharmaceuticals Inc | NASDAQ:REGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
19.39 | 2.07% | 957.00 | 954.85 | 990.00 | 958.13 | 926.94 | 926.94 | 547,374 | 05:00:06 |
By Allison Prang
Earnings at Regeneron Pharmaceuticals Inc. (REGN) declined in the first quarter as expenses grew by 30%, climbing faster than revenue.
Regeneron reported $461.1 million in profit, which was down 3.5% from the comparable quarter a year prior. Earnings were $3.99 a share, down from $4.16 a share.
The company's adjusted earnings were $4.45 a share, down from $4.67 a share. Analysts polled by Refinitiv were expecting $5.46 a share.
Revenue rose 13% to $1.71 billion. Analysts were expecting $1.76 billion. Expenses rose 30%.
Write to Allison Prang at allison.prang@wsj.com
(END) Dow Jones Newswires
May 07, 2019 06:58 ET (10:58 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Regeneron Pharmaceuticals Chart |
1 Month Regeneron Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions